1. | deadRinger | |
2. | jerryff | |
3. | waseem0pola | |
4. | PARTYPLAN09 | |
5. | marketpulse01 |
1. | deadRinger | |
2. | jerryff | |
3. | waseem0pola | |
4. | PARTYPLAN09 | |
5. | marketpulse01 |
1. | waseem0pola 05/03/2018 Marinus Pharmaceuticals Provides Business Update and First Quarter 2018 Financial Results |
2. | jerryff 09/25/2018 Marinus Completes Enrollment in its Magnolia Postpartum Depression Study |
3. | marketpulse01 12/07/2017 Postpartum Depression (PPD) study underway with data expected in early 2018. |
4. | PARTYPLAN09 02/15/2018 Do you think it will continue on this trend? |
5. | deadRinger 06/19/2018 Marinus Pharmaceuticals Initiates Pivotal Phase 3 Trial in Children with CDKL5 Deficiency Disorder |
6. | jerryff 02/15/2018 Headed to 10 soon, within a matter of time |
7. | jerryff 12/07/2017 Here's Why Marinus Pharmaceuticals Rose as Much as 41.1% Thursday |
8. | waseem0pola 02/15/2018 I think that’s exactly the case. |
9. | jerryff 02/15/2018 WOW NICE, that is a 5x return |
10. | PARTYPLAN09 03/22/2018 Marinus Pharmaceuticals Inc (MRNS) Wins a Bull Thanks to Potential in Multiple Central Nervous System Indications |